Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02286401 · ClinicalTrials.gov registry record
Functional Assessment of Coronary Artery Disease by CTA Flow Encoding
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 19
- Enrollment target
NCT02286401: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02286401 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02286401 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this pilot study proposal is to test the ability of Transluminal Flow Encoding (TAFE) to evaluate vessel specific ischemia in patients with a clinical indication for invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurements for suspected coronary disease.
Primary Outcome
We will test the diagnostic accuracy of Coronary CTA, myocardial CT perfusion, and transluminal attenuation flow encoding (TAFE) to predict fractional flow reserve (FFR). Coronary CTA and myocardial CT perfusion results will be dichotomous, either normal or abnormal. Coronary CTA will be defined as abnormal when there is a \> or = 50% diameter stenosis in a coronary vessel. Myocardial CT perfusion will be defined as abnormal when there is a visually determined myocardial perfusion deficit. TAFE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-12-31 |
Why NCT02286401 stopped before completion
NCT02286401 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02286401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02286401 about?
NCT02286401 is a clinical study titled "Functional Assessment of Coronary Artery Disease by CTA Flow Encoding". The purpose of this pilot study proposal is to test the ability of Transluminal Flow Encoding (TAFE) to evaluate vessel specific ischemia in patients with a clinical indication for invasive coronary angiography (ICA) with fractional flow reserve (FFR) measurements for suspected coronary disease.
What is the current status of trial NCT02286401?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2014-10. Estimated completion is 2016-12-31.
Who is sponsoring clinical trial NCT02286401?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia